Trial Profile
Memantine Treatment of Kleptomania: An Open-Label Study.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 26 May 2021
Price :
$35
*
At a glance
- Drugs Memantine (Primary)
- Indications Kleptomania
- Focus Therapeutic Use
- 28 Jun 2012 Actual end date (Jun 2012) added as reported by ClinicalTrials.gov.
- 28 Jun 2012 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 01 Mar 2012 Planned End Date changed from 1 Jun 2012 to 1 Dec 2012 as reported by ClinicalTrials.gov.